A treatment for all lung diseases, a rose petal-inspired coating to make solar cells more efficient and a device to resuscitate newborns are among this month's picks.

GSK remains an investor in the new $600m Fund II, but with a smaller financial presence as SR One positions itself to connect startups to multiple companies across the pharmaceuticals sector.

Miles Gerson, formerly senior investment director at Takeda Ventures, has been promoted to executive investment director.

Regrowing limbs, a cure for AML found at the bottom of the ocean and software for data centres to use 25% less energy are all more science than fiction thanks to these 10 spinouts.

Yamaha Motor's sophomore Exploratory Fund brings the amount it has committed to corporate VC to $300m in the past five years.

Cancer survival rates have increased dramatically over the past century, but immunotherapies are not a holy grail — yet.

Seed-stage investor High-Tech Gründerfonds secured backing from a range of German corporates for its fourth fund, taking its total capital under management past €1.3bn.

Managing partner Vijay Patel tells us why CVS Health Ventures has launched a growth fund as its parent makes a big primary care play.

A cure for diabetes, food made from CO2 and a wound dressing that kills superbugs are all a step closer to reality thanks to these 10 spinouts.

CVC veteran Eric Steager has left Touchdown Ventures and joined Purdue University subsidiary Purdue Ventures as managing director.